UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047464
Receipt number R000053923
Scientific Title Exploratory study of singing effects on mental health
Date of disclosure of the study information 2023/04/18
Last modified on 2024/04/23 18:18:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory study of singing effects on mental health

Acronym

Exploratory study of singing effects on mental health

Scientific Title

Exploratory study of singing effects on mental health

Scientific Title:Acronym

Exploratory study of singing effects on mental health

Region

Japan


Condition

Condition

Healthy male/female adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In order to thoroughly verify some kind of singing effect on mental health

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Simplified questionnaire survey about mental stress (simple ver.: 23 questions)

Key secondary outcomes

1. Tongue-color analysis using the Tongue Image Analyzing System
2. Flicker
3. Acceleration of pulse waveform


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Karaoke-singing 4 songs a time, at the appointed time and place.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Male/female subjects ranging in age from 20 to 59.
(2) Subjects who gave informed consent to participate in this trial after being provided with an explanation of the protocol detail.

Key exclusion criteria

(1) Subjects who take steadily in the health-specific/functional/supplementary/health foods which might affect this trial, and will have any difficulty in giving up taking them after the consent.
(2) Subjects who have taken affecting medicines (e.g., anxiolytic, sleeping pill, antidepressant, and sleep-inducing drug), and have any difficulty in refraining from taking them during this trial.
(3) Subjects who have been diagnosed as depression, or are now under medical treatment for the symptom.
(4) Pregnant, possibly pregnant, and lactating women.
(5) Subjects who are now under other clinical tests with some kind of medicine/food, or participated in those tests within four weeks before this trial, or planning to join those after the consent.
(6) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Fumiko
Middle name
Last name Nakamura

Organization

CPCC Company Limited

Division name

Clinical Support Department

Zip code

103-0021

Address

4F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo 103-0021, Japan

TEL

03-6225-9001

Email

cpcc-contact@cpcc.co.jp


Public contact

Name of contact person

1st name Masanori
Middle name
Last name Numa

Organization

CPCC Company Limited

Division name

Clinical Planning Department

Zip code

103-0021

Address

4F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo 103-0021, Japan

TEL

03-6225-9001

Homepage URL


Email

cpcc-contact@cpcc.co.jp


Sponsor or person

Institute

CPCC Company Limited

Institute

Department

Personal name



Funding Source

Organization

Crane Science Corp.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

DAIICHIKOSHO CO.,LTD

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Chiyoda Paramedical Care Clinic

Address

2F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo 103-0021, Japan

Tel

03-6225-9005

Email

IRB@cpcc.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 03 Month 22 Day

Date of IRB

2022 Year 03 Month 18 Day

Anticipated trial start date

2022 Year 04 Month 18 Day

Last follow-up date

2022 Year 08 Month 26 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 04 Month 12 Day

Last modified on

2024 Year 04 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000053923


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name